Nipocalimab, a first-in-class FcRn blocker being investigated for SjD, met its primary endpoint in the Phase 2 DAHLIAS study ...

Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...

At exposure levels associated with its clinical dose of 150 mg once daily, GLPG3667 showed inhibition of the IFN-α, and IL-23 pathways, comparable to the expected inhibition for the currently approved ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases ...

For millions of people living with back pain, the cause is often elusive. One underrecognized culprit is axial ...

Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition that affects babies born ...

Considering the fast-paced and busy lifestyles most people have these days, having high uric acid levels has become quite a ...

Hijama is considered one of the types of alternative treatment for many diseases, as it depends on the flow of blood circulation to the area where the cups are placed; Hijama benefits for men include ...

At the end of each year, Gamil travels from Tanta to Cairo under the pretext of seeking treatment for his rheumatism, when in ...

The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with distinct vascular and cardiopulmonary features.